Opendata, web and dolomites

OLIGOBINPRO

Non-canonical nucleoside incorporation into synthetic RNA-oligonucleotides: investigations towards the discovery of selective RNA-binding proteins

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 OLIGOBINPRO project word cloud

Explore the words cloud of the OLIGOBINPRO project. It provides you a very rough idea of what is the project "OLIGOBINPRO" about.

human    unavoidable    plethora    natural    biology    ones    fine    money    biological    mrna    techniques    dr    diseases    world    oligoribonucleotides    strands    obesity    responsibility    healthier    possibility    proteins    extracts    prevention    first    tune    difficulty    expectancy    vast    binding    modifications    career    tuning    care    gm    linked    prevent    cancer    occurrence    responsible    quality    sustained    discover    innovative    inspire    genes    meet    incorporated    foundation    synthesis    regulates    modified    am    gene    subsequently    synthesised    mimicking    society    cellular    michaelides    debilitating    rna    oligoribonucleotide    amounts    treating    ms2i6a    patients    life    cm    bottleneck    eliminating    i6a    mechanisms    analysing    incubating    training    spectrometric    exposing    academic    translation    technologies    structure    chemical    therapies    embark    interaction    chemistry    lines    systematically    scientists    cell    canonical    expression    parkinson    aforementioned    bind    multidisciplinary    neurological    mass    treatment    tagging   

Project "OLIGOBINPRO" data sheet

The following table provides information about the project.

Coordinator
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 

Organization address
address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539
website: www.uni-muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 159˙460 €
 EC max contribution 159˙460 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2015
 Duration (year-month-day) from 2015-06-01   to  2017-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) coordinator 159˙460.00

Map

 Project objective

The increase of life expectancy around the world comes at the unavoidable cost of a rise in the occurrence of neurological diseases such as Parkinson’s as well as debilitating ones like cancer. These conditions prevent the possibility of a sustained quality of life and cost society vast amounts of money for the treatment and care of patients. It is the responsibility of scientists to find innovative methods of treating and eliminating these diseases, allowing for a healthier quality of life. Recently, RNA-binding proteins have been linked to biological processes leading to these diseases as well as the expression of genes relating to obesity. A plethora of natural chemical modifications in RNA fine-tune its structure, allowing for this specific interaction which regulates processes such as gene expression and the tuning of translation. Although these have been known for years, their binding proteins have not been systematically studied. The difficulty of the chemical synthesis of modified oligoribonucleotides represents the major bottleneck in this field. The overall aim of this project is to discover RNA-binding proteins which bind to the non-canonical modifications Am, Cm, Gm, i6A and ms2i6A which were identified in the mRNA of human cancer cell lines. These will first be synthesised and then incorporated into oligoribonucleotide strands mimicking natural mRNA. By incubating with cellular extracts, we subsequently aim to identify their binding proteins by tagging them with novel technologies and analysing them using mass spectrometric techniques. This project will inspire and offer unique training to Dr. Michaelides by exposing him to this multidisciplinary field where chemistry and biology meet, enabling him to embark on his own academic career. Furthermore, it will set the foundation for the better understanding of the mechanisms responsible for the aforementioned conditions, which will in the long term lead to the design of new therapies for their prevention.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OLIGOBINPRO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OLIGOBINPRO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

MacMeninges (2019)

Control of Central Nervous Sytem inflammation by meningeal macrophages, and its impairment upon aging

Read More  

5G-ACE (2019)

Beyond 5G: 3D Network Modelling for THz-based Ultra-Fast Small Cells

Read More  

IMPRESS (2019)

Integrated Modular Power Conversion for Renewable Energy Systems with Storage

Read More